Association Between High-Sensitivity Cardiac Troponin and Risk of Stroke in 96 702 Individuals: A Meta-Analysis

Leonie H A Broersen1,2, Helena Stengl1,2, Christian H Nolte1,2,3,4,5

  • 1From the Klinik für Neurologie mit Experimenteller Neurologie (L.H.A.B., H.S., C.H.N., M.E., J.F.S.), Charité-Universitätsmedizin Berlin, Germany.

Stroke
|February 21, 2020
PubMed

Insights

High-sensitivity cardiac troponin (hs-cTn) indicates myocardial injury and is a risk marker for incident stroke in the general population and patients with atrial fibrillation. Further research is needed for high-risk populations, particularly those with a history of ischemic stroke.

Area of Science:

  • Cardiology
  • Neurology
  • Biomarker Research

Background:

  • Myocardial injury, indicated by high-sensitivity cardiac troponin (hs-cTn), is a known risk factor for cardiovascular events.
  • The association between hs-cTn levels and incident stroke risk requires further elucidation across diverse populations.

Purpose of the Study:

  • To estimate the risk of incident stroke associated with varying levels of hs-cTn.
  • To analyze this risk in the general population, patients with atrial fibrillation, and patients with a history of stroke.

Main Methods:

  • A systematic meta-analysis of randomized controlled trials and cohort studies was conducted.
  • Searches were performed in Embase, PubMed, and Web of Science up to March 14, 2019.
  • Pooled adjusted hazard ratios were calculated using a random-effects model, accounting for heterogeneity and stroke classification.

Main Results:

  • In the general population (77,978 participants), high hs-cTn levels were associated with a 1.25-fold increased risk of incident stroke (CI, 1.10-1.40).
  • When using categorical data, the risk increased to 1.58 (CI, 1.26-1.90).
  • In patients with atrial fibrillation (18,725 participants), high hs-cTn levels showed a 1.95-fold increased risk of incident stroke (CI, 1.29-2.62).

Conclusions:

  • High-sensitivity cardiac troponin is a significant risk marker for incident stroke across different populations.
  • The effect size of hs-cTn as a stroke risk marker varies among subgroups.
  • Further research is warranted to investigate the hs-cTn-stroke association in high-risk groups, especially those with prior ischemic stroke.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
309
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
707
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
472
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
154
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
604
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
288